I’m starting a company. An internet-scale dataset is created every day that can be used to cure diseases. ㅤㅤㅤㅤㅤㅤㅤㅤㅤㅤㅤㅤㅤㅤㅤ Yet decisions for developing new drugs use a tiny fraction of it. ㅤㅤㅤㅤㅤㅤㅤㅤㅤㅤㅤ After years of building and investing in therapeutics

Great stuff Michael Retchin!

#ICYMI our Chief Medical Officer, Charlotte McKee, M.D., was featured on the “In Sickness” podcast, hosted by Bob Coughlin and @PaulKidwell, where they discussed cystic fibrosis (#CF) and the lifetime commitment needed for its care. insickness.org/podcast/episod…

#CGT companies: Are you experiencing questions surrounding buying vs. building manufacturing space? JLL’s Matt Jackson and Joe Judge are partnering with #ARM to host a webinar on strategic considerations behind the “buy vs. build" dilemma. bit.ly/3Yhectq

Eli Lilly has agreed to acquire Morphic Therapeutic for approximately $3.2 billion, in a deal designed to bolster the buyer’s pipeline with chronic disease candidates led by MORF-057, a Phase II treatment for inflammatory bowel disease (IBD). bit.ly/3LwSeLk

Rentschler has opened its production line at its 22,000 square-feet facility in Milford, Massachusetts, about 20 miles southwest of Boston. bit.ly/3LBTSva

The world has lost a true hero. Jack Connors represented everything good about Boston. He was family and a friend, but more importantly, he played a major role in every important decision that I have made in my life. Rest easy in paradise knowing you changed the world.

bit.ly/3WIGUls

MilliporeSigma has invested €6.6 million ($7.1 million) at its Nantong, China facility to meet the growing local demand for cell culture media (CCM) products. bit.ly/3ym6VOo

Imagine a workplace that not only draws the best and brightest talent to your life sciences company, but also drives innovation and speed to market. Find out how to make that dream a reality by downloading our three-point guide: bit.ly/4c4RbwU

Autobahn Labs accelerates drug development through partnership with Charles River Labs, leveraging their capabilities while Charles River pursues animal-free testing alternatives. bit.ly/3YQeiZl

FDA expands its Total Product Life Cycle Advisory Program (TAP) to include radiological, ophthalmic, and orthopedic devices, enhancing the development of innovative medical technologies and timely communications with stakeholders. bit.ly/4d839qN

Customers can access Celltheon’s antibody and mAb platforms with cell line development (CLD) timelines within 12 weeks, says Cytovance. bit.ly/3AwJu5p

Mirus Bio specializes in the development and commercialization of transfection reagents, such as TransIT-VirusGEN®. bit.ly/3AjKB8C

Amgen India will be located in Hitec City, a suburb of Hyderabad, occupying six floors of the RMZ Spire Tower 110. bit.ly/3M9SIr7

The countries invested in six projects to bolster health-emergency preparedness. bit.ly/3SV4nxE

The organization asks stakeholders from academia and industry for their ideas to solve challenges within the sector. bit.ly/3SXL4E0

A full-circle moment. My son Bobby was born over 22 years ago with Cystic Fibrosis. It changed the course of our lives and my career. I couldn't be more proud that Bobby has decided to work in the life science industry at MassBio! #fullcircle

The firm’s CEO says manufacturing prices for the traditionally expensive treatments will decrease as technology improves. bit.ly/3MpQ945